Yanli Qu

机构：Liaoning Cancer Hospital & Institute, China Medical University · ORCID：0000-0002-7533-6815

发表论文 60 篇 · 总被引 1195 次 · h-index 12

代表论文

• The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and kidney stones: a cross-sectional study (2024 · Lipids in Health and Disease · 被引 46)
• High-dose hyperfractionated simultaneous integrated boost radiotherapy versus standard-dose radiotherapy for limited-stage small-cell lung cancer in China: a multicentre, open-label, randomised, phase 3 trial (2024 · The Lancet Respiratory Medicine · 被引 43)
• First-Line Pembrolizumab Plus Chemotherapy for HER2-Negative Advanced Gastric Cancer: China Subgroup Analysis of the Randomized Phase 3 KEYNOTE-859 Study (2025 · Advances in Therapy · 被引 9)
• Isomalto-Oligosaccharide Potentiates Alleviating Effects of Intermittent Fasting on Obesity-Related Cognitive Impairment during Weight Loss and the Rebound Weight Gain (2024 · Journal of Agricultural and Food Chemistry · 被引 9)
• Clinical trial landscape for TIL therapy: emerging insights and future directions in oncology (2024 · Journal of Translational Medicine · 被引 8)
• Immune checkpoint inhibitors for patients with mismatch repair deficient or microsatellite instability-high advanced cancers: a meta-analysis of phase I–III clinical trials (2024 · International Journal of Surgery · 被引 5)